Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.80 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.80 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.80 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.80 |
| ▸ | ACHE | P22303 | 3/20 | 0.65 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | AR | P10275 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26946 | 0.89 | ESR1 (1.00) | ESR1ESR2PDCD1CD274ACHE | |
| SCHEMBL10593295 | 0.89 | ESR1 (1.00) | ESR1ESR2PDCD1CD274ACHE | |
| SCHEMBL14158781 | 0.88 | ESR1 (0.61) | ESR1ESR2PDCD1CD274ACHE | |
| Methane SCHEMBL21952131 | 0.87 | ESR1 (0.94) | ESR1ESR2PDCD1CD274ACHE | |
| Ammonia Solution, Strong SCHEMBL7989093 | 0.87 | ESR1 (0.94) | ESR1ESR2PDCD1CD274ACHE | |
| SCHEMBL146509 | 0.87 | ESR1 (0.55) | ESR1ESR2PDCD1CD274ACHE | |
| Ammonia Solution, Strong SCHEMBL7995783 | 0.84 | ESR1 (0.52) | ESR1ESR2PDCD1CD274ACHE | |
| SCHEMBL6563988 | 0.82 | ESR1 (0.84) | ESR1ESR2PDCD1CD274MAPT | |
| SCHEMBL20763933 | 0.82 | ACHE (0.68) | ESR1ESR2PDCD1CD274ACHE | |
| SCHEMBL735987 | 0.82 | ACHE (0.68) | ESR1ESR2PDCD1CD274ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3212614-B1 | PROCESS FOR MAKING BENZOXAZINES | CYTEC IND INC (US) | 2019-05-01 | — | — | EP | disclosed |
| US-9880322-B2 | Benzyl (meth)acrylate monomers suitable for microstructured optical films | 3M INNOVATIVE PROPERTIES CO. (US) | 2018-01-30 | — | — | US | disclosed |
| US-20170369679-A1 | NOR-HALS COMPOUNDS AS FLAME RETARDANTS | BASF SE (DE) | 2017-12-28 | — | — | US | disclosed |
| US-9783655-B2 | NOR-HALS compounds as flame retardants | BASF SE (DE) | 2017-10-10 | — | — | US | disclosed |
| US-20160229989-A1 | NOR-HALS COMPOUNDS AS FLAME RETARDANTS | BASF SE (DE) | 2016-08-11 | — | — | US | disclosed |
| US-9360591-B2 | Microstructured film comprising nanoparticles and monomer comprising alkylene oxide repeat units | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-06-07 | — | — | US | disclosed |
| US-20150284535-A1 | NOR-HALS COMPOUNDS AS FLAME RETARDANTS | BASF SE (DE) | 2015-10-08 | — | — | US | disclosed |
| US-20150241599-A1 | MICROSTRUCTURED FILM COMPRISING NANOPARTICLES AND MONOMER COMPRISING ALKYLENE OXIDE REPEAT UNITS | 3M INNOVATIVE PROPERTIES COMPANY | 2015-08-27 | — | — | US | disclosed |
| US-8877838-B2 | Melamine phenylphosphinate flame retardant compositions | BASF SE (DE) | 2014-11-04 | — | — | US | disclosed |
| US-20140316032-A1 | P-N-COMPOUNDS AS FLAME RETARDANTS | BASF SE (DE) | 2014-10-23 | — | — | US | disclosed |
| EP-0468921-A1 | Aqueous dispersions of slightly soluble UV absorbing agents | CIBA-GEIGY AG (CH) | 1992-01-29 | — | — | EP | disclosed |
| US-5009668-A | Mixture of assistants and its use in the dyeing of synthetic fibre materials: acid ester of oxyalkylated phendl, nonionic surfactant and dye carrier | CIBA-GEIGY CORPORATION (US) | 1991-04-23 | — | — | US | disclosed |
| US-5009669-A | Aqueous dispensions of 2-(2'-hydroxyphenyl)benzotriazoles | CIBA-GEIGY CORPORATION (US) | 1991-04-23 | — | — | US | disclosed |
| EP-0414631-A1 | Auxiliary agent mixture and its use in dyeing polyester fibre materials | CIBA-GEIGY AG (CH) | 1991-02-27 | — | — | EP | disclosed |
| US-4950810-A | Selective process for preparting 2,4- or 3,6-di-substituted phenol compounds | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1990-08-21 | — | — | US | disclosed |
| EP-0382138-A1 | Auxiliary mixture and its use in dyeing synthetic fibrous materials | CIBA-GEIGY AG (CH) | 1990-08-16 | — | — | EP | disclosed |
| EP-0345219-A1 | Aqueous dispersions of 2-(2'-hydroxyphenyl) benzotriazoles | CIBA-GEIGY AG (CH) | 1989-12-06 | — | — | EP | disclosed |
| EP-0335674-A2 | Selective process for preparing 2,4- or 3,6-di-substituted phenol compounds | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1989-10-04 | — | — | EP | disclosed |
| US-4564632-A | Insecticidal and acaricidal agents and their use | BAYER AKTIENGESELLSCHAFT (DE) | 1986-01-14 | — | — | US | disclosed |
| US-4380671-A | LEWIS ACID CATALYZED REACTION OF SULFUR DICHLORIDE AND ALKYLPHENOL | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1983-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170369679-A1 | NOR-HALS COMPOUNDS AS FLAME RETARDANTS | PFAS, NONO, PARG | ESR1 4170/4885ESR2 3543/4885PDCD1 3643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.